CGC

Canopy Growth Corporation

$0.59

-4.88%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc.

Source: Yahoo Finance
AI summary

Price & performance

1M-27.3%
3M-28.1%
YTD-43.5%
1Y-50.9%
52-week range—
Beta1.53
Full chart and returns against a benchmark

Q-Score

32/ 100

Quality against peers; 50 is the peer median.

Growth37
Risk37
Performance31
Valuation52
Profitability38
Leverage28
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$204.3M+8.7%
Net income-$188.8M
Net margin-92.4%+96.8 pts
Historical fundamentals

Red flags in filings

5active red flags
Going-concern doubtJun 15, 2026
Material weakness in controlsJun 15, 2026
Restated financialsMay 15, 2026
Filings, findings and the timeline

Revenue exposure

90%of revenue from outside the US
Canada65%
Germany22%
United States10%
Regions, segments, customers and suppliers

Valuation

CGCIndustryP/E—35.25P/S1.222.74EV/EBITDA—16.35P/B0.582.46PEG—0.87
Dividend yield0.00%
Every valuation metric

Earnings

Feb 5next report, before the open
EPS estimate$-0.03
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate